Alexander L. Johnson - Aug 20, 2024 Form 4 Insider Report for CareDx, Inc. (CDNA)

Signature
/s/ Alexander L. Johnson
Stock symbol
CDNA
Transactions as of
Aug 20, 2024
Transactions value $
-$578,594
Form type
4
Date filed
8/22/2024, 05:15 PM
Previous filing
Aug 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $927K +39.5K +13.85% $23.48 324K Aug 20, 2024 Direct
transaction CDNA Common Stock Sale -$1.31M -39.5K -12.16% $33.17 285K Aug 20, 2024 Direct F1
transaction CDNA Common Stock Options Exercise $506K +21.6K +7.56% $23.48 307K Aug 21, 2024 Direct
transaction CDNA Common Stock Sale -$702K -21.6K -7.03% $32.58 285K Aug 21, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -39.5K -35.69% $0.00 71.1K Aug 20, 2024 Common Stock 39.5K $23.48 Direct F3
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -21.6K -30.31% $0.00 49.6K Aug 21, 2024 Common Stock 21.6K $23.48 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.75, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.50 to $32.98, inclusive.
F3 1/4th of the shares subject to this option vested on June 16, 2023 and the remaining 3/4th of the shares subject to this option will vest monthly thereafter in 35 equal installments of 2,347 shares and one installment of 281 shares, until fully vested.

Remarks:

President of Patient and Testing Services